MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0041073
Stanglob Pharma Private Limited
Stanglob Pharma Private Limited - trading in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹1.09 Lakh
▼ 24% YoY
Net profit · FY 2024
₹2,681
Net margin 2.5%
EBITDA · FY 2024
₹2,681
EBITDA margin 2.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Stanglob Pharma Private Limited
Data last updated:
Stanglob Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC362475.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandra Kant Shukla and Nandini Shukla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2943/13 III Floor Ranjeetnagar Near South Patel Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.09 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹2,681 (net margin 2.5%) and EBITDA of ₹2,681 (EBITDA margin 2.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
Stanglob Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0041073).
Company Details of Stanglob Pharma Private Limited
CIN U51909DL2020PTC362475
Registration Number 362475
Incorporation Date 02 March 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0041073
Recognitions & Rankings of Stanglob Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2943/13 III Floor Ranjeetnagar Near South Patel Nagar, New Delhi, Delhi, India – 110008
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Stanglob Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Stanglob Pharma Private Limited
The main business activity of Stanglob Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stanglob Pharma Private Limited FY 2025 filings available
Stanglob Pharma Private Limited reported revenue of ₹1.09 Lakh (down 24% YoY) for FY 2024.
Revenue · FY 2024
₹1.09 Lakh ▼ 24%
Net profit · FY 2024
₹2,681 margin 2.5%
EBITDA · FY 2024
₹2,681 margin 2.5%
Compounded Annual Growth Rate (CAGR) of Stanglob Pharma Private Limited
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 221%
3 years · compounded
▲ 28%
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 24% fall in the latest year. EBITDA rose 221% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stanglob Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2,681 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2,681 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stanglob Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stanglob Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Stanglob Pharma Private Limited
Stanglob Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Kant Shukla | Director | 02 Mar 2020 | 6 Years 7 Months | Current |
| Nandini Shukla | Director | 02 Mar 2020 | 6 Years 7 Months | Current |
Peer Comparison of Stanglob Pharma Private Limited
Stanglob Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leons Professionals (OPC) Private Limited | ₹1.09 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Delhi, India |
| W2g Sales & Marketing Private Limited | ₹1.09 Lakh (FY 2019) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Prit Trading Private Limited | ₹1.09 Lakh (FY 2020) | •••• | •••• | -43.0% | •••• | Dhanbad, Jharkhand, India |
| Blaze Tradecom Pvt. Ltd. | ₹1.09 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Kolkata, West Bengal, India |
| Agnijwaala Vincom Private Limited | ₹1.09 Lakh (FY 2025) | •••• | •••• | 42.0% | •••• | Durgapur, West Bengal, India |
| Stanglob Pharma Private Limited this company | ₹1.09 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | New Delhi, Delhi, India |
| Jhilmil Financial Consultants Private Limited | ₹1.09 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Kolkata, West Bengal, India |
| Netlord Marketing Private Limited | ₹1.09 Lakh (FY 2022) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Votary Trading Private Limited | ₹1.09 Lakh (FY 2018) | •••• | •••• | -81.0% | •••• | Kolkata, West Bengal, India |
| Shriidhi Vastuvibes (OPC) Private Limited | ₹1.09 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Survedoo Online Private Limited | ₹1.09 Lakh (FY 2025) | •••• | •••• | 322.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Stanglob Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Stanglob Pharma Private Limited
Stanglob Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Stanglob Pharma Private Limited
Employment history and EPFO contributions of people linked to Stanglob Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stanglob Pharma Private Limited
Stanglob Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Chandra Kant Shukla was appointed as Director on 02 Mar 2020.
AGM
Stanglob Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stanglob Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Chandra Kant Shukla was appointed as Director.
Appointed
Nandini Shukla was appointed as Director.
Incorporation
02 Mar 2020
Stanglob Pharma Private Limited was registered on 02 Mar 2020 with Roc Delhi I & aged 6 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Stanglob Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stanglob Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stanglob Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stanglob Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stanglob Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stanglob Pharma Private Limited
Stanglob Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 02 March 2020 (6+ years old) and is registered under CIN U51909DL2020PTC362475.
Stanglob Pharma reported revenue of ₹1.09 Lakh for FY 2024 (down 24% YoY).
Stanglob Pharma has 2 current directors:
- Chandra Kant Shukla - Director
- Nandini Shukla - Director
Stanglob Pharma reported a net profit of ₹2,681 (net margin 2.5%) and EBITDA of ₹2,681 (EBITDA margin 2.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stanglob Pharma is -1% over three years. In the latest year (FY 2024) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Stanglob Pharma is U51909DL2020PTC362475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanglob Pharma was incorporated on 02 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Stanglob Pharma by revenue are Leons Professionals (OPC) Private Limited, W2g Sales & Marketing Private Limited, Prit Trading Private Limited, Blaze Tradecom Pvt. Ltd, Agnijwaala Vincom Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Chandra Kant Shukla was appointed as Director on 02 Mar 2020. Nandini Shukla was appointed as Director on 02 Mar 2020.
Yes, Stanglob Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0041073).
The registered office of Stanglob Pharma is at 294313 III Floor Ranjeetnagar Near South Patel Nagar, New Delhi, Delhi, India – 110008.